Afssaps releases test results on PIP implants but genotoxicity concerns persist
This article was originally published in RAJ Devices
Much-awaited tests carried out by French regulatory agency Afssaps on the banned silicone filled breast implants made by Poly Implant Prothèse (PIP) have confirmed the products have an increased risk of rupture1. A number of other healthcare concerns associated with the unapproved and previously untested filler used in the implants have also been verified. The results of ongoing genotoxicity tests, however, are not expected before early next year, the agency said.
You may also be interested in...
The Trump administration does not believe its partnership with industry on therapeutics for COVID-19 should include conditions on pricing, US Health Secretary Alex Azar tells Congress.